Comparative Assessment Of Hscrp And Apolipoprotein B As Ascvd Risk Biomarkers

被引：0
|
作者：
Amusat, Saheed Oladele
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2024年 / 44卷
关键词：
D O I：
10.1161/atvb.44.suppl_1.1020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1020
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comparative Assessment of hsCRP and Apolipoprotein B as ASCVD Risk Biomarkers
    Amusat, Saheed Oladele
    CIRCULATION, 2024, 150
  • [2] Comparative assessment of hsCRP and apolipoprotein B as ASCVD risk biomarkers
    Amusat, S.
    CLINICA CHIMICA ACTA, 2024, 558 : 48 - 48
  • [3] Apolipoprotein B modifies the association between lipoprotein(a) and ASCVD risk
    Lai, Yuhui
    Zhang, Shaozhao
    Guo, Yue
    Xu, Chaoguang
    Huang, Mengting
    Zhan, Rongjian
    Liu, Menghui
    Xiong, Zhenyu
    Huang, Yiquan
    Liao, Xinxue
    Ma, Yuedong
    Zhuang, Xiaodong
    Jiang, Jingzhou
    Wu, Xing
    AMERICAN HEART JOURNAL, 2025, 281 : 157 - 167
  • [4] Apolipoprotein B in cardiovascular risk assessment
    Ahmad, Maud
    Sniderman, Allan D.
    Hegele, Robert A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (33) : E1124 - E1124
  • [5] The use of apolipoprotein B in risk assessment
    不详
    FUTURE CARDIOLOGY, 2006, 2 (03) : 252 - 252
  • [6] Apolipoprotein B in the assessment of cardiovascular risk
    Ahmad, Maud
    Sniderman, Allan D.
    Hegele, Robert A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (47) : E1644 - E1645
  • [7] Biomarkers to Establish Low ASCVD Risk It Takes Two
    McEvoy, John W.
    Liew, Chee H.
    Connolly, Niall P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (04) : 371 - 373
  • [8] Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
    Dansinger, Michael L.
    Williams, Paul T.
    Superko, H. Robert
    Schaefer, Ernst J.
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)
  • [9] Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
    Michael L. Dansinger
    Paul T. Williams
    H. Robert Superko
    Ernst J. Schaefer
    Lipids in Health and Disease, 18
  • [10] Apolipoprotein B: its advantages in the assessment of atherosclerotic cardiovascular risk
    Coniglio, Raul Ignacio
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2021, 55 (01): : 11 - 20
12345